4D Molecular Therapeutics, Inc. (FDMT)

SEC filing

4D Molecular Therapeutics, Inc.

FDMT · CIK 1650648

4 · Sep 16, 2026 · Director, See Remarks Kirn David sold 58.33K shares at $13.90/share ($811.0K)

Director, See Remarks Kirn David sold 58.33K shares at $13.90/share ($811.0K)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.